Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$441M |
| 2 |
Broadcom
AVGO
|
+$328M |
| 3 |
Pfizer
PFE
|
+$292M |
| 4 |
Tesla
TSLA
|
+$252M |
| 5 |
IBM
IBM
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$295M |
| 2 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$138M |
| 3 |
General Mills
GIS
|
+$131M |
| 4 |
Chevron
CVX
|
+$116M |
| 5 |
PPG Industries
PPG
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Financials | 13.22% |
| 3 | Healthcare | 13.19% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Frontier Group Holdings
ULCC
$1.72B
| $2.63M | ﹤0.01% |
271,078
+42,228
| +18% | +$518K |
|
|
SWI
2502
DELISTED
SolarWinds Corporation Common Stock
SWI
| $2.63M | ﹤0.01% |
339,194
+15,638
| +5% | +$150K |
|
2503
Kiniksa Pharmaceuticals
KNSA
$5.69B
| $2.63M | ﹤0.01% |
204,500
+120,997
| +145% | +$1.38M |
|
|
BASE
2504
DELISTED
Couchbase
BASE
| $2.61M | ﹤0.01% |
182,903
+86,365
| +89% | +$1.4M |
|
2505
Relmada Therapeutics
RLMD
$547M
| $2.61M | ﹤0.01% |
70,515
-1,991
| -3% | -$55.2K |
|
2506
Central Garden & Pet Co
CENT
$2.72B
| $2.6M | ﹤0.01% |
90,284
+3,399
| +4% | +$113K |
|
2507
Anika Therapeutics
ANIK
$278M
| $2.6M | ﹤0.01% |
109,007
+4,935
| +5% | +$114K |
|
2508
Atara Biotherapeutics
ATRA
$76.9M
| $2.59M | ﹤0.01% |
27,421
+699
| +3% | +$78.5K |
|
2509
908 Devices
MASS
$338M
| $2.59M | ﹤0.01% |
157,434
+23,821
| +18% | +$463K |
|
2510
Custom Truck One Source
CTOS
$2.45B
| $2.59M | ﹤0.01% |
444,029
+69,674
| +19% | +$434K |
|
2511
Barnes & Noble Education
BNED
$446M
| $2.59M | ﹤0.01% |
10,782
+4,361
| +68% | +$1.17M |
|
2512
1-800-Flowers.com
FLWS
$265M
| $2.58M | ﹤0.01% |
397,910
+90,282
| +29% | +$799K |
|
|
CORZ
2513
DELISTED
Core Scientific, Inc. Common Stock
CORZ
| $2.57M | ﹤0.01% |
1,978,568
+356,738
| +22% | +$759K |
|
2514
Stratasys
SSYS
$695M
| $2.57M | ﹤0.01% |
178,021
+10,252
| +6% | +$183K |
|
2515
RE/MAX Holdings
RMAX
$195M
| $2.56M | ﹤0.01% |
135,568
-2,950
| -2% | -$70.1K |
|
2516
FRP Holdings
FRPH
$437M
| $2.56M | ﹤0.01% |
94,264
+1,696
| +2% | +$49.4K |
|
2517
The RMR Group
RMR
$325M
| $2.54M | ﹤0.01% |
107,081
-1,554
| -1% | -$42.4K |
|
2518
Arcturus Therapeutics
ARCT
$169M
| $2.53M | ﹤0.01% |
170,824
+14,566
| +9% | +$244K |
|
2519
Rush Enterprises Class B
RUSHB
$6.14B
| $2.52M | ﹤0.01% |
78,960
+2,922
| +4% | +$104K |
|
2520
Cogent Biosciences
COGT
$6.64B
| $2.51M | ﹤0.01% |
168,379
+55,184
| +49% | +$756K |
|
2521
Organogenesis Holdings
ORGO
$306M
| $2.51M | ﹤0.01% |
775,063
+107,118
| +16% | +$484K |
|
|
MLNK
2522
DELISTED
MeridianLink
MLNK
| $2.49M | ﹤0.01% |
153,060
+36,459
| +31% | +$636K |
|
2523
NovaGold Resources
NG
$2.58B
| $2.48M | ﹤0.01% |
529,454
+1,188
| +0.2% | +$5.5K |
|
2524
Energy Vault
NRGV
$556M
| $2.48M | ﹤0.01% |
470,100
+137,987
| +42% | +$750K |
|
2525
Tidewater
TDW
$3.63B
| $2.48M | ﹤0.01% |
114,230
+12,079
| +12% | +$257K |
|
Similar funds
Charles Schwab's Q3 2022 Portfolio in Review
As of Q3 2022, Charles Schwab held 3,614 positions worth $279B, down 2.9% from $287B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab deployed $8.77B of net new capital in Q3 2022, opening 79 new positions and adding to 2,461 existing holdings. Its largest new stake was JPMorgan Ultra-Short Income ETF: 2,974,316 shares worth $149M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares National Muni Bond ETF, an estimated $295M trimmed.
- Charles Schwab's largest Q3 2022 buy was JPMorgan Ultra-Short Income ETF: 2,974,316 shares worth $149M.
- Charles Schwab added most to Verizon in Q3 2022, an estimated $441M increase.
- Charles Schwab's biggest Q3 2022 reduction was iShares National Muni Bond ETF, cutting an estimated $295M.
- Charles Schwab fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $91.4M.
- Charles Schwab's ten largest holdings make up 17% of its $279B portfolio in Q3 2022.
- Charles Schwab opened 79 new positions and closed 105 in Q3 2022.
- Charles Schwab's portfolio value fell 2.9% quarter-over-quarter to $279B.
Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.